Hombach A - Search Results

1

XIAP targeting sensitizes Hodgkin lymphoma cells for cytolytic T-cell attack.

Kashkar H, Seeger JM, Hombach A, Deggerich A, Yazdanpanah B, Utermöhlen O, Heimlich G, Abken H, Krönke M. Kashkar H, et al. Among authors: hombach a. Blood. 2006 Nov 15;108(10):3434-40. doi: 10.1182/blood-2006-05-021675. Epub 2006 Jul 25. Blood. 2006. PMID: 16868249 Free article.

2

Chimeric T-cell receptors: highly specific tools to target cytotoxic T-lymphocytes to tumour cells.

Abken H, Hombach A, Heuser C, Sircar R, Pohl C, Reinhold U. Abken H, et al. Among authors: hombach a. Cancer Treat Rev. 1997 Mar;23(2):97-112. doi: 10.1016/s0305-7372(97)90023-2. Cancer Treat Rev. 1997. PMID: 9225961 Review. No abstract available.

3

T cell targeting of TAG72+ tumor cells by a chimeric receptor with antibody-like specificity for a carbohydrate epitope.

Hombach A, Heuser C, Sircar R, Tillmann T, Diehl V, Kruis W, Pohl C, Abken H. Hombach A, et al. Gastroenterology. 1997 Oct;113(4):1163-70. doi: 10.1053/gast.1997.v113.pm9322511. Gastroenterology. 1997. PMID: 9322511

4

Can combined T-cell- and antibody-based immunotherapy outsmart tumor cells?

Abken H, Hombach A, Reinhold U, Ferrone S. Abken H, et al. Among authors: hombach a. Immunol Today. 1998 Jan;19(1):2-5. doi: 10.1016/s0167-5699(97)01191-2. Immunol Today. 1998. PMID: 9465480 Review. No abstract available.

5

An anti-CD30 chimeric receptor that mediates CD3-zeta-independent T-cell activation against Hodgkin's lymphoma cells in the presence of soluble CD30.

Hombach A, Heuser C, Sircar R, Tillmann T, Diehl V, Pohl C, Abken H. Hombach A, et al. Cancer Res. 1998 Mar 15;58(6):1116-9. Cancer Res. 1998. PMID: 9515791

6

Isolation of single chain antibody fragments with specificity for cell surface antigens by phage display utilizing internal image anti-idiotypic antibodies.

Hombach A, Pohl C, Heuser C, Sircar R, Diehl V, Abken H. Hombach A, et al. J Immunol Methods. 1998 Sep 1;218(1-2):53-61. doi: 10.1016/s0022-1759(98)00115-x. J Immunol Methods. 1998. PMID: 9819122

7

Generation of the single chain antibody fragment conserves the idiotypic profile of the anti-CD30 monoclonal antibody HRS3.

Hombach A, Pohl C, Heuser C, Sircar R, Koch D, Diehl V, Abken H. Hombach A, et al. Scand J Immunol. 1998 Nov;48(5):497-501. Scand J Immunol. 1998. PMID: 9822258 Free article.

8

Grafting T cells with tumor specificity: the chimeric receptor strategy for use in immunotherapy of malignant diseases.

Hombach A, Pohl C, Reinhold U, Abken H. Hombach A, et al. Hybridoma. 1999 Feb;18(1):57-61. doi: 10.1089/hyb.1999.18.57. Hybridoma. 1999. PMID: 10211789 Review.

9

Specific lysis of melanoma cells by receptor grafted T cells is enhanced by anti-idiotypic monoclonal antibodies directed to the scFv domain of the receptor.

Reinhold U, Liu L, Lüdtke-Handjery HC, Heuser C, Hombach A, Wang X, Tilgen W, Ferrone S, Abken H. Reinhold U, et al. Among authors: hombach a. J Invest Dermatol. 1999 May;112(5):744-50. doi: 10.1046/j.1523-1747.1999.00586.x. J Invest Dermatol. 1999. PMID: 10233766 Free article.

10

A chimeric receptor that selectively targets membrane-bound carcinoembryonic antigen (mCEA) in the presence of soluble CEA.

Hombach A, Koch D, Sircar R, Heuser C, Diehl V, Kruis W, Pohl C, Abken H. Hombach A, et al. Gene Ther. 1999 Feb;6(2):300-4. doi: 10.1038/sj.gt.3300813. Gene Ther. 1999. PMID: 10435115

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters